Literature DB >> 7954809

Müllerian-inhibiting substance function during mammalian sexual development.

R R Behringer1, M J Finegold, R L Cate.   

Abstract

To investigate the role of Müllerian-inhibiting substance (MIS) in mammalian sexual development, we generated MIS-deficient mice. Although MIS-deficient males had testes that were fully descended and produced functional sperm, they also developed female reproductive organs, which interfered with sperm transfer into females, rendering most of these males infertile. Their testes had Leydig cell hyperplasia and, in one instance, neoplasia. The actions of the two primary hormones of male sexual differentiation were genetically eliminated using the testicular feminization (Tfm) mutation in combination with the MIS mutant allele. XY Tfm/MIS double mutants developed as females, with a uterus, coiled oviducts, and no male reproductive organs except undescended dysfunctional testes. These results suggest that eliminating the presumptive female reproductive tract in male fetuses facilitates fertility and that in testes MIS is a negative regulator of Leydig cell proliferation. Eliminating the presumptive male reproductive tract is necessary for proper oviductal morphogenesis during female mouse development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7954809     DOI: 10.1016/0092-8674(94)90251-8

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  121 in total

1.  In vivo convergence of BMP and MAPK signaling pathways: impact of differential Smad1 phosphorylation on development and homeostasis.

Authors:  Josée Aubin; Alice Davy; Philippe Soriano
Journal:  Genes Dev       Date:  2004-06-15       Impact factor: 11.361

Review 2.  TGF-β superfamily: how does it regulate testis development.

Authors:  Yun-Shu Fan; Yan-Jun Hu; Wan-Xi Yang
Journal:  Mol Biol Rep       Date:  2011-09-27       Impact factor: 2.316

3.  Activin A, a product of fetal Leydig cells, is a unique paracrine regulator of Sertoli cell proliferation and fetal testis cord expansion.

Authors:  Denise R Archambeault; Humphrey Hung-Chang Yao
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

4.  Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta.

Authors:  Nathalie di Clemente; Soazik P Jamin; Alexey Lugovskoy; Paul Carmillo; Christian Ehrenfels; Jean-Yves Picard; Adrian Whitty; Nathalie Josso; R Blake Pepinsky; Richard L Cate
Journal:  Mol Endocrinol       Date:  2010-09-22

5.  The industrial chemical bisphenol A (BPA) interferes with proliferative activity and development of steroidogenic capacity in rat Leydig cells.

Authors:  Manjunatha K Nanjappa; Liz Simon; Benson T Akingbemi
Journal:  Biol Reprod       Date:  2012-05-03       Impact factor: 4.285

Review 6.  Stem Leydig cells: from fetal to aged animals.

Authors:  Haolin Chen; Erin Stanley; Shiying Jin; Barry R Zirkin
Journal:  Birth Defects Res C Embryo Today       Date:  2010-12

Review 7.  From gene networks underlying sex determination and gonadal differentiation to the development of neural networks regulating sociosexual behavior.

Authors:  David Crews; Wendy Lou; Alison Fleming; Sonoko Ogawa
Journal:  Brain Res       Date:  2006-08-14       Impact factor: 3.252

8.  Combined loss of the GATA4 and GATA6 transcription factors in male mice disrupts testicular development and confers adrenal-like function in the testes.

Authors:  Maria B Padua; Tianyu Jiang; Deborah A Morse; Shawna C Fox; Heather M Hatch; Sergei G Tevosian
Journal:  Endocrinology       Date:  2015-02-10       Impact factor: 4.736

9.  Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance.

Authors:  Elizabeth J Renaud; David T MacLaughlin; Esther Oliva; Bo R Rueda; Patricia K Donahoe
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-23       Impact factor: 11.205

Review 10.  Regulation of the ovarian reserve by members of the transforming growth factor beta family.

Authors:  Stephanie A Pangas
Journal:  Mol Reprod Dev       Date:  2012-09-11       Impact factor: 2.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.